X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
hematology (236) 236
humans (228) 228
index medicus (219) 219
oncology (195) 195
female (123) 123
male (121) 121
middle aged (111) 111
aged (105) 105
adult (82) 82
dermatology (64) 64
leukemia, lymphocytic, chronic, b-cell - drug therapy (60) 60
aged, 80 and over (59) 59
rituximab (51) 51
antineoplastic combined chemotherapy protocols - therapeutic use (42) 42
prognosis (39) 39
treatment outcome (38) 38
skin neoplasms - pathology (37) 37
survival (37) 37
fludarabine (36) 36
chronic lymphocytic leukemia (34) 34
chemotherapy (33) 33
medicine, general & internal (33) 33
leukemia, lymphocytic, chronic, b-cell - pathology (32) 32
therapy (32) 32
abridged index medicus (30) 30
cll (29) 29
chronic lymphocytic-leukemia (27) 27
cyclophosphamide (27) 27
disease-free survival (26) 26
cancer (25) 25
medicine, research & experimental (25) 25
melanoma - pathology (25) 25
vidarabine - analogs & derivatives (25) 25
cutaneous melanoma (24) 24
leukemia, lymphocytic, chronic, b-cell - mortality (24) 24
melanoma (24) 24
antineoplastic agents - therapeutic use (23) 23
diagnosis (23) 23
leukemia (23) 23
expression (22) 22
follow-up studies (22) 22
leukemia, lymphocytic, chronic, b-cell - genetics (22) 22
risk factors (21) 21
immunotherapy (19) 19
prospective studies (18) 18
radiology, nuclear medicine & medical imaging (18) 18
antineoplastic combined chemotherapy protocols - adverse effects (17) 17
chronic lymphatic leukemia (17) 17
malignant-melanoma (17) 17
adolescent (16) 16
leukemia, lymphocytic, chronic, b-cell - diagnosis (16) 16
alemtuzumab (15) 15
apoptosis (15) 15
care and treatment (15) 15
follow-up (15) 15
neoplasm staging (15) 15
previously untreated patients (15) 15
survival rate (15) 15
trial (15) 15
analysis (14) 14
animals (14) 14
chemoimmunotherapy (14) 14
combined modality therapy (14) 14
cyclophosphamide - administration & dosage (14) 14
disease progression (14) 14
leukemia, lymphocytic, chronic, b-cell - metabolism (14) 14
medicine & public health (14) 14
survival analysis (14) 14
ultrasonography (14) 14
vidarabine - administration & dosage (14) 14
young adult (14) 14
antineoplastic agents - administration & dosage (13) 13
antineoplastic agents - adverse effects (13) 13
biopsy (13) 13
drug therapy (13) 13
immunology (13) 13
leukemia, lymphocytic, chronic, b-cell - therapy (13) 13
research (13) 13
retrospective studies (13) 13
tumors (13) 13
chlorambucil (12) 12
drug resistance, neoplasm (12) 12
hematology, oncology and palliative medicine (12) 12
leukemia, lymphocytic, chronic, b-cell - immunology (12) 12
lymphoma (12) 12
minimal residual disease (12) 12
mutation (12) 12
tumor cells, cultured (12) 12
antibodies, monoclonal - therapeutic use (11) 11
b-cells (11) 11
clinical trials (11) 11
diagnosis, differential (11) 11
genetics & heredity (11) 11
germany (11) 11
initial therapy (11) 11
kaplan-meier estimate (11) 11
lymphatic leukemia (11) 11
melanoma - diagnostic imaging (11) 11
open-label (11) 11
phase-ii trial (11) 11
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Leukemia, ISSN 0887-6924, 04/2015, Volume 29, Issue 4, pp. 981 - 984
SURVIVAL | CELLS | APOPTOSIS | ONCOLOGY | ABT-737 | RECEPTOR | KAPPA-B | HEMATOLOGY | Oxygen - pharmacology | Humans | Myeloid Cell Leukemia Sequence 1 Protein - metabolism | bcl-X Protein - genetics | Drug Resistance, Neoplasm | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | Cell Hypoxia | Proto-Oncogene Proteins c-bcl-2 - metabolism | CD40 Ligand - metabolism | Biphenyl Compounds - pharmacology | Nitrophenols - pharmacology | Antineoplastic Agents - pharmacology | p38 Mitogen-Activated Protein Kinases - metabolism | B-Lymphocytes - pathology | B-Lymphocytes - metabolism | Myeloid Cell Leukemia Sequence 1 Protein - antagonists & inhibitors | Signal Transduction | Nitrogen Mustard Compounds - pharmacology | Cells, Cultured | p38 Mitogen-Activated Protein Kinases - genetics | Vidarabine - analogs & derivatives | Gene Expression Regulation, Leukemic | Sulfonamides - pharmacology | Piperazines - pharmacology | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Myeloid Cell Leukemia Sequence 1 Protein - genetics | B-Lymphocytes - drug effects | Vidarabine - pharmacology | Bridged Bicyclo Compounds, Heterocyclic - pharmacology | Bendamustine Hydrochloride | CD40 Ligand - genetics | Leukemia, Lymphocytic, Chronic, B-Cell - metabolism | Enzyme Activation | bcl-X Protein - metabolism | Proto-Oncogene Proteins c-bcl-2 - genetics | Chronic lymphocytic leukemia | Care and treatment | Physiological aspects | Development and progression | Genetic aspects | Research | Gene expression | Mitogen-activated protein kinases | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 01/2016, Volume 127, Issue 2, pp. 208 - 215
Journal Article
Nature Communications, ISSN 2041-1723, 12/2018, Volume 9, Issue 1, pp. 727 - 8
Journal Article
Leukemia, ISSN 0887-6924, 03/2008, Volume 22, Issue 3, pp. 585 - 592
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9747, pp. 1164 - 1174
Summary Background On the basis of promising results that were reported in several phase 2 trials, we investigated whether the addition of the monoclonal... 
Internal Medicine | CYTOKINE-RELEASE | MEDICINE, GENERAL & INTERNAL | PLUS CYCLOPHOSPHAMIDE | CHEMOIMMUNOTHERAPY | PROGRESSION-FREE SURVIVAL | INITIAL THERAPY | LYMPHOMA | STEM-CELL TRANSPLANTATION | EXPRESSION | III TRIAL | DELETION | Cyclophosphamide - administration & dosage | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Incidence | Leukopenia - chemically induced | Aged, 80 and over | Adult | Female | Neutropenia - chemically induced | Severity of Illness Index | Antibodies, Monoclonal, Murine-Derived | Drug Administration Schedule | Immunologic Factors - administration & dosage | Kaplan-Meier Estimate | Rituximab | Treatment Outcome | Vidarabine - analogs & derivatives | Disease Progression | Disease-Free Survival | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Leukemia, Lymphocytic, Chronic, B-Cell - mortality | Vidarabine - administration & dosage | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Chronic lymphocytic leukemia | Cyclophosphamide | Fludarabine | Patient outcomes | Dosage and administration | Research | Drug therapy | Studies | Clinical trials | Mutation | Medical statistics | Epidemiology | Annual meetings | Teaching hospitals | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article